These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 19210109

  • 1. Esomeprazole: a proton pump inhibitor.
    Vachhani R, Olds G, Velanovich V.
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
    [Abstract] [Full Text] [Related]

  • 2. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
    McKeage K, Blick SK, Croxtall JD, Lyseng-Williamson KA, Keating GM.
    Drugs; 2008 Feb; 68(11):1571-607. PubMed ID: 18627213
    [Abstract] [Full Text] [Related]

  • 3. Esomeprazole for asthma.
    Wise MP, Saayman AG, Frost PJ.
    N Engl J Med; 2009 Jul 09; 361(2):207; author reply 207-8. PubMed ID: 19593856
    [No Abstract] [Full Text] [Related]

  • 4. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.
    Pallotta S, Pace F, Marelli S.
    Expert Rev Gastroenterol Hepatol; 2008 Aug 09; 2(4):509-22. PubMed ID: 19072398
    [Abstract] [Full Text] [Related]

  • 5. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR.
    Expert Rev Gastroenterol Hepatol; 2007 Dec 09; 1(2):197-205. PubMed ID: 19072410
    [Abstract] [Full Text] [Related]

  • 6. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
    Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino E.
    Eur J Intern Med; 2017 Jan 09; 37():19-24. PubMed ID: 27784575
    [Abstract] [Full Text] [Related]

  • 7. Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.
    Sandström M, Davidson G, Tolia V, Sullivan JE, Långström G, Lundborg P, Brown K.
    Clin Ther; 2012 Aug 09; 34(8):1828-38. PubMed ID: 22832034
    [Abstract] [Full Text] [Related]

  • 8. Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.
    Tonini M, Vigneri S, Neri M, Cuomo R, Savarino V, Pace F.
    Digestion; 2007 Aug 09; 76(3-4):171-8. PubMed ID: 18046084
    [Abstract] [Full Text] [Related]

  • 9. [Proton pump inhibitor in the management of acid-related disorders in Japan: history and perspective].
    Sugano K.
    Nihon Rinsho; 2007 Dec 09; 65(12):2375-81. PubMed ID: 18069285
    [Abstract] [Full Text] [Related]

  • 10. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
    Franke A, Hepp C, Harder H, Beglinger C, Singer MV.
    Scand J Gastroenterol; 2008 Dec 09; 43(12):1425-31. PubMed ID: 18924018
    [Abstract] [Full Text] [Related]

  • 11. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.
    Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C.
    Am J Gastroenterol; 2006 Apr 09; 101(4):701-10. PubMed ID: 16494585
    [Abstract] [Full Text] [Related]

  • 12. Rabeprazole for the treatment of acid-related disorders.
    Marelli S, Pace F.
    Expert Rev Gastroenterol Hepatol; 2012 Aug 09; 6(4):423-35. PubMed ID: 22928894
    [Abstract] [Full Text] [Related]

  • 13. Esomeprazole for asthma.
    Hsu CS, Kao JH.
    N Engl J Med; 2009 Jul 09; 361(2):206; author reply 207-8. PubMed ID: 19587349
    [No Abstract] [Full Text] [Related]

  • 14. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
    Teng M, Khoo AL, Zhao YJ, Lin L, Lim BP, Wu TS, Dan YY.
    J Clin Pharm Ther; 2015 Aug 09; 40(4):368-75. PubMed ID: 25893507
    [Abstract] [Full Text] [Related]

  • 15. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
    Tulassay Z, Stolte M, Sjölund M, Engstrand L, Butruk E, Malfertheiner P, Dite P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Nagy P.
    Eur J Gastroenterol Hepatol; 2008 Jun 09; 20(6):526-36. PubMed ID: 18467912
    [Abstract] [Full Text] [Related]

  • 16. Esomeprazole magnesium (Nexium).
    Baker DE.
    Rev Gastroenterol Disord; 2001 Jun 09; 1(1):32-41. PubMed ID: 12120118
    [Abstract] [Full Text] [Related]

  • 17. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
    Moayyedi P, Armstrong D, Hunt RH, Lei Y, Bukoski M, White RJ.
    Am J Gastroenterol; 2010 Nov 09; 105(11):2341-6. PubMed ID: 20842110
    [Abstract] [Full Text] [Related]

  • 18. The Australian rise of esomeprazole-was expenditure on samples a contributor?
    Kyle GJ, Nissen LM, Tett SE.
    Pharmacoepidemiol Drug Saf; 2009 Jan 09; 18(1):62-8. PubMed ID: 19111014
    [Abstract] [Full Text] [Related]

  • 19. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R.
    Minerva Gastroenterol Dietol; 2000 Dec 09; 46(4):231-41. PubMed ID: 19320085
    [No Abstract] [Full Text] [Related]

  • 20. Naproxen/esomeprazole (Vimovo).
    Med Lett Drugs Ther; 2010 Sep 20; 52(1347):74-5. PubMed ID: 20847717
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.